JPRN-UMIN000006108招募中2 期
Clinical trial for development of topical rapamycin treatment for white macules due to tuberous sclerosis complex, vitiligo vulgaris, and other congenital diseases - Clinical trial for development of topical rapamycin treatment for white macules due to tuberous sclerosis complex, vitiligo vulgaris, and other congenital diseases
Department of Dermatology Graduate School of Medicine, Osaka University0 个研究点目标入组 21 人开始时间: 2011年8月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with severe mental retardation who cannot carry out this treatment plan. 2) Patients who have allergy to macrolide antibiotics. 3) Patients who received oral administration of rapamycin or RAD001 within six months prior to the study entry. 4) Patients who received topical treatment of tacrolimus, vitamin D, or steroid within three months prior to the study entry. 5) Patients who received phototherapy or surgical therapy within six months prior to the study entry. 6) Patients during pregnancy or lactation 7) Patients who were judged unsuitable for this study by the investigator.
研究者
相似试验
招募中
2 期
Clinical trial for development of topical rapamycin treatment for rosacearosaceaJPRN-UMIN000008315Department of Dermatology Graduate School of Medicine, Osaka University5
招募中
2 期
Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1neurofibromatosis type1JPRN-UMIN000015081Department of Dermatology Graduate School of Medicine, Osaka University3
已完成
2 期
Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complextuberous sclerosis complexJPRN-UMIN000002844Department of Dermatology Graduate School of Medicine, Osaka University21
已完成
1 期
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)Tuberous SclerosisNeurofibromatosesNeurofibromaAngiofibromaNCT01031901The University of Texas Health Science Center, Houston52
已完成
3 期
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous SclerosisFacial AngiofibromaNCT03140449National Taiwan University Hospital52